{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:27:49Z","timestamp":1793262469638,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T00:00:00Z","timestamp":1374192000000},"content-version":"vor","delay-in-days":230,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ajhg.2012.10.014","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T14:51:52Z","timestamp":1354200712000},"page":"1108-1114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia"],"prefix":"10.1016","volume":"91","author":[{"given":"Florence","family":"Lorget","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Kaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Benoist-Lasselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Mugniery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Oppeneer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan\u00a0J.","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean\u00a0M.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Bullens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Bunting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie\u00a0S.","family":"Tsuruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles\u00a0A.","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Di\u00a0Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Munnich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Legeai-Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajhg.2012.10.014_bib1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","article-title":"Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia","volume":"371","author":"Rousseau","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2012.10.014_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(94)90302-6","article-title":"Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia","volume":"78","author":"Shiang","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ajhg.2012.10.014_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","article-title":"Achondroplasia","volume":"370","author":"Horton","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajhg.2012.10.014_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOP.0b013e32833b7a69","article-title":"Achondroplasia: Pathogenesis and implications for future treatment","volume":"22","author":"Laederich","year":"2010","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.ajhg.2012.10.014_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/hmg\/ddr514","article-title":"A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model","volume":"21","author":"Jonquoy","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2012.10.014_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/8.1.35","article-title":"A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors","volume":"8","author":"Li","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ajhg.2012.10.014_bib7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/386288a0","article-title":"Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism","volume":"386","author":"Su","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.ajhg.2012.10.014_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bone.2003.09.002","article-title":"Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias","volume":"34","author":"Legeai-Mallet","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.ajhg.2012.10.014_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","article-title":"Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype","volume":"18","author":"Murakami","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.ajhg.2012.10.014_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jor.21262","article-title":"Genetic inactivation of ERK1 and ERK2 in chondrocytes promotes bone growth and enlarges the spinal canal","volume":"29","author":"Sebastian","year":"2011","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.ajhg.2012.10.014_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","article-title":"Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway","volume":"10","author":"Yasoda","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ajhg.2012.10.014_bib12","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1242\/jcs.02618","article-title":"Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis","volume":"118","author":"Krejci","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ajhg.2012.10.014_bib13","doi-asserted-by":"crossref","first-page":"11695","DOI":"10.1074\/jbc.273.19.11695","article-title":"Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide\/guanylyl cyclase-B pathway","volume":"273","author":"Yasoda","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ajhg.2012.10.014_bib14","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ajhg.2012.10.014_bib15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/humu.20511","article-title":"Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation","volume":"28","author":"Bocciardi","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ajhg.2012.10.014_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/humu.20611","article-title":"A cluster of translocation breakpoints in 2q37 is associated with overexpression of NPPC in patients with a similar overgrowth phenotype","volume":"28","author":"Moncla","year":"2007","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ajhg.2012.10.014_bib17","doi-asserted-by":"crossref","first-page":"14288","DOI":"10.1074\/jbc.C500024200","article-title":"A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn\/cn mouse","volume":"280","author":"Tsuji","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ajhg.2012.10.014_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1086\/422013","article-title":"Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux","volume":"75","author":"Bartels","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ajhg.2012.10.014_bib19","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/en.2008-1676","article-title":"Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias","volume":"150","author":"Yasoda","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajhg.2012.10.014_bib20","first-page":"1428","article-title":"Bioactivity and metabolism of C-type natriuretic peptide in normal man","volume":"78","author":"Hunt","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ajhg.2012.10.014_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbadis.2008.11.010","article-title":"Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia","volume":"1792","author":"Pannier","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ajhg.2012.10.014_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.2010.189092","article-title":"Clinical management of achondroplasia","volume":"97","author":"Wright","year":"2012","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ajhg.2012.10.014_bib23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/oxfordjournals.jbchem.a022591","article-title":"Concentration of mRNA for the natriuretic peptide receptor-C in hypertrophic chondrocytes of the fetal mouse tibia","volume":"127","author":"Yamashita","year":"2000","journal-title":"J. Biochem."},{"key":"10.1016\/j.ajhg.2012.10.014_bib24","doi-asserted-by":"crossref","first-page":"13007","DOI":"10.1074\/jbc.273.21.13007","article-title":"Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia","volume":"273","author":"Legeai-Mallet","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ajhg.2012.10.014_bib25","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.febslet.2007.04.079","article-title":"Human immortalized chondrocytes carrying heterozygous FGFR3 mutations: An in\u00a0vitro model to study chondrodysplasias","volume":"581","author":"Benoist-Lasselin","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ajhg.2012.10.014_bib26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bone.2005.03.006","article-title":"Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells","volume":"36","author":"Ozasa","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.ajhg.2012.10.014_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bone.2006.10.013","article-title":"Fibroblast growth factor expression in the postnatal growth plate","volume":"40","author":"Lazarus","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.ajhg.2012.10.014_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1203\/00006450-200002000-00007","article-title":"Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP","volume":"47","author":"Mericq","year":"2000","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ajhg.2012.10.014_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-213X-7-18","article-title":"C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways","volume":"7","author":"Agoston","year":"2007","journal-title":"BMC Dev. Biol."},{"key":"10.1016\/j.ajhg.2012.10.014_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ng0496-390","article-title":"Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3","volume":"12","author":"Colvin","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ajhg.2012.10.014_bib31","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0092-8674(00)81069-7","article-title":"Fibroblast growth factor receptor 3 is a negative regulator of bone growth","volume":"84","author":"Deng","year":"1996","journal-title":"Cell"}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000292971200537X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000292971200537X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:12:04Z","timestamp":1757574724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000292971200537X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S000292971200537X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajhg.2012.10.014","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the Therapeutic Potential of a CNP Analog in a Fgfr3 Mouse Model Recapitulating Achondroplasia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Human Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajhg.2012.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}